◆ 会议时间：2022年10月23日至26日
◆ 会议地点：美国 圣安东尼奥(San Antonio)
◆ 会议简介：
2022年第64届美国放射肿瘤学会(ASTRO)年会将于2022年10月23日至26日在美国圣安东尼奥举行。ASTRO年会（美国放疗年会）是世界放射肿瘤学界最重要的年度会议，每年都会吸引超过10,000名来自世界各地的相关专业人士前来参会。
美国放射肿瘤学会（ASTRO）成立于1958年，是世界上首屈一指的放射肿瘤学组织。ASTRO现拥有超过10000名会员，包括医生、护士、生物学家、物理学家、放疗技师、剂量师和其他专业从事放谢治疗的医疗保健专业人员。
作为领先的放射肿瘤学组织，ASTRO致力于通过专业的教育和培训，支持临床实践和卫生政策标准，促进科学研究和宣传宣等手段改善对患者的护理。——未经许可禁止复制摘录转载本站任何内容-领域国际医学会议网（lingyuint.com）。
ASTRO 2022 - American Society for Radiation Oncology (ASTRO) 64th Annual Meeting
Date: October 23 - 26, 2022
Venue: Henry B. Gonzalez Convention Center | San Antonio
, USA
Exhibit Dates: October 23 - 25, 2022
Mark your calendar now for the 64th ASTRO Annual Meeting! This is the premier radiation oncology scientific event in the world with more than 11,000 attendees each year. The 2022 ASTRO Annual Meeting—AI and EI: Caring for Patients in a Wireless World—will include a full program with engaging educational and scientific sessions, live SA-CME courses and networking events. We’ll highlight the potential of AI, Big Data and scientific advances while showcasing the central role of human interaction in caring for and curing our patients! We’re excited to continue popular offerings from recent years – such as expanded Cancer Breakthroughs sessions and Storytelling – along with deeper dives into important topics with our Master Class series. We look forward to another memorable meeting and can’t wait to see you in San Antonio!
ASTRO 2022 摘要征集 - Abstract submission：
常规摘要提交截止日期
Deadline to Submit: 11:59 p.m. Pacific time, Tuesday, March 1, 2022
点此提交摘要>>>Submit Abstract>>>
LBA摘要提交日期
Late-breaking Abstracts: The late-breaking abstract submission site will open on July 25, 2022, and close August 10, 2022.
摘要提交费：
There is a $60 fee per abstract that is non-refundable.
点此了解更多投稿信息>>>>>
Eligibility
- Sponsorship or ASTRO membership is not required to submit an abstract.
- Abstracts must be received by 11:59 p.m. Pacific time, Tuesday, March 1, 2022.
- All studies in oncology, radiation oncology and radiation-therapy for non-oncologic conditions are eligible for submission. This includes basic and translational science, technology-related, health services research, epidemiologic, patient-focused clinical studies and all phases of trials.
- An abstract may only be submitted once. Abstracts of clinically-related subjects should be combined into a single abstract. Submission of multiple abstracts on a single study may result in the rejection of one or more abstracts.
- Submit new research. Data from the long-term follow-up of previously presented clinical trials may be submitted only if significant new information can be shown.
- Obligation to Register: Acceptance of the abstract by the committee obligates the author to present the paper and pay the meeting registration fee. If circumstances prevent attendance, you must notify ASTRO and arrange for an alternate presenter, preferably a co-author in the Speaker Center. If you do not register and attend the meeting, your abstract will be removed from the program.
- Disclosures: The submitter must complete the disclosures for the presenter and all co-authors. Use this form to gather all co-author information and use it when entering the co-authors into the abstract submission site.
Important Deadlines-重要截止日期
- Abstracts must be received by 11:59 p.m. Pacific time, Tuesday, March 1, 2022. Abstracts may be edited up until the deadline. Abstracts will be considered ineligible for review if they are incomplete. Abstracts that are unpaid or have payment issues will not be considered. If you do not receive a confirmation receipt, follow up with ASTRO to confirm your “complete” status.
- Revisions: Please proof your abstract carefully for formatting, spelling and data errors. Pay special attention to the author order and presenting author designation. Review your confirmation email, as this is how the abstract will be published. Errors can be corrected if sent to ASTRO by June 30, 2022. After this date, we cannot make any corrections. This rule is strictly enforced. Please note: revisions should not be substantive, and should not alter the results or the conclusions of the abstract. Revisions are meant only to correct errors that were made in the initial submission.
- Notifications: The person listed as Presenting Author will be notified via email of the disposition of the abstract by late-May 2022. Abstract acceptance obligates the author to present the paper and pay the meeting registration fee. If circumstances prevent attendance, you must notify ASTRO and arrange for an alternate presenter, preferably a co-author.
- Withdrawals: If you choose to withdraw your abstract, please change your decision to “withdraw” in the Speaker Center by June 30, 2022 and notify ASTRO staff via email. After this date, your abstract will be published exactly as it was submitted in the International Journal of Radiation Oncology • Biology • Physics (Red Journal).
- Late-breaking Abstracts: The late-breaking abstract submission site will open on July 25, 2022, and close August 10, 2022.
- Submission of an abstract conveys permission to be posted online and printed in the International Journal of Radiation Oncology • Biology • Physics (Red Journal) (www.redjournal.org).
Presenting Author Responsibility-展示作者的责任
- An individual may submit more than one abstract in which they are indicated as the presenting author. However, they may only present one oral presentation. If more than one abstract is selected for oral presentation, an alternate presenter must be assigned, preferably a co-author (this does not apply to poster presentations).
- It is the submitter’s responsibility to ensure up-to-date and accurate disclosures are submitted for each co-author on the abstract. ASTRO manages and reports all disclosures as submitted. Potential conflicts with commercial interest for the presenting author and all co-authors must be disclosed at the time of submission.
- The presenting author will receive all notifications and email communications related to the accepted abstract(s). The presenting author is responsible for informing all co-authors of acceptance to ASTRO’s Annual Meeting.
- ASTRO has developed a policy to handle any violations to the ASTRO Disclosure policy. Any reported violations will be researched and handled according to policy, which can include removal from presenting at future conferences.
- Obligation to Register: Acceptance of an abstract obligates the author to present the paper and pay the meeting registration fee. If circumstances prevent attendance, you must notify ASTRO and arrange for an alternate presenter, preferably a co-author. If the presenting author does not register and attend the meeting, your abstract will be removed from the program.
Presentation at Other Meetings
- Abstracts should contain new material that has not been presented or published prior to the ASTRO Annual Meeting, October 23-26, 2022. Previously presented abstracts will not be eligible for ASTRO’s official Press Program or Plenary Session.
- If the same abstract is accepted for presentation at another major medical meeting or accepted for publication after March 1, 2022, the presenting author must notify ASTRO. The Scientific Committee will review and decide on a case-by-case basis if the abstract will remain in the program.
Properly Formatted Abstract
- Abstracts must be properly formatted and organized into four sections identified by the following bolded headers: Purpose/Objectives, Materials/Methods, Results and Conclusions.
- Abstracts should include a scientific hypothesis in the Purpose/Objectives section, and implications for research, policy or practice in the Conclusions section, when applicable.
- Presentations must give a balanced view of therapeutic options. Brand names of pharmaceuticals and trade names of medical devices cannot be used in the title or body of the abstract. ASTRO reserves the right to replace proprietary names with generic names.
- Institution names should not be included in the title or body of the abstract. Alternative language is “at one institution” or “a multi-institution” study, etc. This does not apply to cooperative research group names.
- The abstract title should not include results.
- The abstract cannot contain illustrations, images or graphs. If the abstract is accepted, presenters may include these items in their on-site presentations.
- An abstract may contain one small table. The maximum character limit, including the title and body of the abstract, is 2,600 characters. Spaces are not counted.
- A maximum of 20 authors’ names may be listed on each abstract. There are no exceptions. Authorship credit should only be given if all three of the following criteria are met. There is not mechanism for listing co-lead authors, or co-PI’s. Each author must have made substantial contributions to:
- conception and design, or analysis and interpretation of data, and
- drafting the abstract or revising it critically for important intellectual content, and
- final approval of the version to be submitted/published.
Late-breaking Abstracts
- The late-breaking abstract submission site will open on July 25, 2022, and close August 10, 2022.
- A late-breaking abstract is an original research abstract containing important late-breaking research results that were not available prior to the regular abstract submission deadline. The research is limited to highly significant and timely findings and cannot be a revision of an abstract submitted prior to the regular submission deadline. Trials in progress are not eligible to be submitted as late-breaking abstracts.
- Late-breaking abstracts must not have been submitted, presented, accepted for presentation or published in any other scientific venue.
- A special panel of peer reviewers will review the late-breaking abstracts and the corresponding author will be notified of the abstract status by the end of August 2022.
ASTRO2022 注册费：
IN-PERSON FULL CONFERENCE
The In-person Full Conference experience includes:
- Admission to all Education and Scientific Sessions.
- Access to Poster Sessions.
- Access to Exhibit Hall.
- NEW! Admission to the Exhibit Hall Networking Reception.
- NEW! Admission to the PRO Program.
- NEW! Admission to all Live SA-CME sessions.
- Ability to add ticketed events to your registration.
- Ability to network with colleagues.
- Continuing medical education (CME) credits.
- NEW! onDemand access to session content.
| Registration Category |
Early-bird:
Until July 28 |
Advance:
July 29 - September 15 |
Late:
After September 15 |
Member
|
$699 |
$799 |
$899 |
Emeritus Member
|
$399 |
$499 |
$599 |
Member-in-Training (Resident/Fellow)
|
$399 |
$499 |
$599 |
Allied Professional Member Rate
|
$499 |
$599 |
$699 |
Postdoctoral Fellow Member
|
$399 |
$499 |
$599 |
Student/Grad Student Member
|
$99 |
$149 |
$199 |
| Nonmember |
$1,149 |
$1,299 |
$1,499 |
Allied Professional Nonmember Rate
|
$649 |
$749 |
$849 |
Resident/Fellow/Postdoctoral Fellow Nonmember
|
$449 |
$549 |
$649 |
Patient Advocate Nonmember
|
$99 |
$149 |
$199 |
Student/Grad Student Nonmember
|
$149 |
$199 |
$249 |
ASRT Registrant
|
$499 |
$599 |
$699 |
SROA Registrant
|
$499 |
$599 |
$699 |
VIRTUAL FULL CONFERENCE
The Virtual Full Conference experience includes:
- Real-time access to Education and Scientific sessions streamed live from the Annual Meeting.
- NEW! Access to the PRO Program.
- NEW! Access to all Live SA-CME sessions.
- Continuing medical education (CME) credits.
- NEW! onDemand access to session content.
- Access to the Annual Meeting virtual poster library.
| Registration Category |
Early-bird:
Until July 28 |
Advance:
July 29 - September 15 |
Late:
After September 15 |
Member
|
$799 |
$899 |
$999 |
Emeritus Member
|
$499 |
$599 |
$699 |
Member-in-Training (Resident/Fellow)
|
$499 |
$599 |
$699 |
Allied Professional Member Rate
(Nurse, Nurse Practitioner, Dosimetrist, RT, Physician Assistant) |
$599 |
$699 |
$799 |
Postdoctoral Fellow Member
|
$499 |
$599 |
$699 |
Student/Grad Student Member
|
$199 |
$249 |
$299 |
| Nonmember |
$1,249 |
$1,399 |
$1,549 |
Allied Professional Nonmember Rate
(Nurse, Nurse Practitioner, Dosimetrist, RT, Physician Assistant) |
$749 |
$849 |
$949 |
Resident/Fellow/Postdoctoral Fellow Nonmember
|
$549 |
$649 |
$749 |
Patient Advocate Nonmember
|
$199 |
$249 |
$299 |
Student/Grad Student Nonmember
|
$249 |
$299 |
$349 |
PRO WEEKEND (IN PERSON)
The Practical Radiation Oncology (PRO) Program is a two-day program specifically designed for the community practice radiation oncologist. This program is held Saturday and Sunday to allow doctors unable to leave their practice for an entire week with the ability to attend ASTRO's Annual Meeting. Program content is curated to keep in mind the ins and outs of a community practice and will include disease site reviews, interactive case-based discussions, a coding update and a scientific overview.
PRO Weekend registration includes:
- Access to PRO Program held on Saturday and Sunday.
- Admission to in-person Education and Scientific Sessions on Saturday and Sunday only.
- Exhibit Hall access on Sunday only.
- Admission to the PRO Live SA-CME session.
- Access to Poster Sessions on Sunday only.
- Ability to add in-person ticketed events for Saturday and Sunday.
| Registration Category |
Early-bird:
Until July 28 |
Advance:
July 29- September 15 |
Late:
After September 15 |
| Member (All Categories) |
$399 |
$499 |
$599 |
| Nonmember (All Categories) |
$499 |
$599 |
$699 |
Exhibit Hall Only
The Exhibit Hall Only registration will only be available after September 15 and onsite. This includes access to the Exhibit Hall only during show hours Sunday, October 23 through Tuesday, October 25 and the Exhibit Hall Networking Reception on Monday.
| Registration Category |
Late: After September 15 |
| Member (All Categories) |
$250 |
| Nonmember (All Categories) |
$500 |
ASRT and SROA Exhibit Hall Only
ASTRO offers registration discounts to ASRT and SROA registered attendees who would like to attend the in-person full conference education and scientific program of the ASTRO Annual Meeting. To view rates for the in-person full conference, click on the tab above for registration options. To receive this reduced rate, you must provide the registration confirmation number received from ASRT or SROA when you registered.
In addition, all ASRT and SROA attendees receive FREE admission and will be registered for the ASTRO Exhibit Hall. ASRT and SROA attendees must wear an ASTRO issued badge to visit the ASTRO Exhibit Hall. For the health and safety of all registrants, ASRT and SROA attendees are required to acknowledge ASTRO’s COVID-19 Health and Safety Policies and Attendee Policies to obtain their complimentary badge. ASRT and SROA attendees must provide their consent to ASTRO’s COVID-19 Health and Safety Policies and pick up their badge on-site at ASTRO Registration, located in Hall 1 of the Henry B. Gonzalez Convention Center.
Please note that Exhibit Hall Only registration does NOT provide access to ASTRO sessions, ticketed events, or onDemand. ASRT and SROA registered conference attendees will need to register for the In Person Full Conference Experience to have access.
Spouse/Guest
Includes the following:
- Exhibit Hall access Sunday-Tuesday during hall hours.
- Exhibit Hall Networking Reception on Monday.
This registration does not include access to in-person ASTRO sessions or ticketed events. Spouse/Guest registrants are not eligible for continuing medical educational credits. Only In person full conference attendees are eligible to register one Spouse/Guest.
IMPORTANT! In order for Spouse/Guest to attend the Annual Meeting and receive a meeting badge they must provide consent to our COVID-19 Health and Safety Form. We will have the consent form available here once registration has opened.
| Registration Category |
Early Bird:
Until July 28 |
Advance:
July 29 - September 15 |
Late:
After September 15 |
| Spouse/Guest |
$75 |
$100 |
$125 |
参展联系：
John Barrett
john.barrett@spargoinc.com
+1 703-654-6490
ASTRO 2022年美国放疗年会-ASTRO放射治疗肿瘤年会-ASTRO放射年会-美国放射肿瘤学年会
◆ 参会对象：
放射科医师，肿瘤科医师，护士，生物学家，物理学家，放疗技师，放射剂量师，药疗企业代表，以及其他相关卫生保健专业人士等等。
|
